Stem cell therapy is a regenerative medicine technique consisting in introducing new cells into a damaged tissue in order to restore it. In this paper we present our multidisciplinary approach about the possible use of the Human Mesenchymal Stem Cells in treating heart failure. A multidisciplinary team composed by biologists, mathematicians, cardiologists and bioengineers was selected in order to investigate the feasibility of repairing the necrotic tissue damaged by myocardial infarction by means of Mesenchymal Stem Cells and to implement a new software simulator able to reproduce cells implantation, migration and proliferation. In the first step, biologists and cardiologists studied the Human Mesenchymal Stem Cells and measured selected parameters. Stem cells were isolated and cultured in order to study their growth and characterization. In the second step, mathematicians and bioengineers developed a new numerical model based on the studies and the data measured during in vitro experiments. The first version of the software simulator named MiStTher is able to give a first qualitative description of the stem cell therapy in some simplified schemes.
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
Tel.: +1 703 830 6300
Fax: +1 703 830 2300 email@example.com
(Corporate matters and books only) IOS Press c/o Accucoms US, Inc.
For North America Sales and Customer Service
West Point Commons
Lansdale PA 19446
Tel.: +1 866 855 8967
Fax: +1 215 660 5042 firstname.lastname@example.org